3 shares you should have bought in August

Which shares were the winners in August and does Alan Oscroft think they’re worth buying in September too?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

We’ve seen something of a pattern in August, as sectors that were unfairly battered in the immediate aftermath of the EU referendum have been coming back. But which shares have done best?

Insurance rebound

In the insurance sector, Standard Life (LSE: SL) has done very nicely with a 36% rebound since the shares’ low point on 6 July, reaching 358p today. Standard Life shares are now more highly valued than they were on Brexit day, despite a sharp drop immediately afterwards. Along with the general recovery in the sector, first-half results on 9 August helped too, showing boosts across the board, so are Standard Life shares still worth buying if you missed the panic sale?

A strong earnings forecast for the full year puts the shares on a forward P/E of 13.7, which is slightly below the long-term FTSE 100 average, and that would drop to 12.6 on 2016 predictions. That alone wouldn’t attract me, but dividends expected to yield 5.5% this year and 5.9% next tip the balance — and just think, if you’d bought after the initial Brexit panic, you could have locked in effective yields of 7.5% and 8.1%!

Keep an eye out for other likely insurance bargains too — Aviva is up 21% since the crash, with RSA insurance up 12%, both on lower 2017 P/E ratings.

Solid housing

There’s been a housebuilding resurgence since the post-Brexit depths, with Barratt Developments (LSE: BDEV) one of the FTSE 100’s biggest winners in August. If you’d got in on 6 July, you’d be 50% up today with the shares on 500p. That’s not back to pre-vote levels yet, but it does highlight the irrationality of those who thought the UK’s chronic housing shortage was suddenly going to end once we leave the EU.

Barratt shares are now on a forward P/E of only 9.2, and even though the earnings growth of the last few years is set to slow, that still looks like a buy to me — especially as there are dividends yielding better than 6% on the cards, and they’d be strongly covered by earnings.

The other major housebuilders have performed similarly in August — Taylor Wimpey shares are up 42%, Persimmon up 46%, and Bovis Homes up 42%. And they all still look good value to me.

Potash profits

Turning away from the Bexit effect, just look what’s happened to Sirius Minerals (LSE: SXX)! The company, with its Potash project in North Yorkshire, has seen its share price soar by 140% since 6 July, and by 71% in August alone, to 44.6p as I write.

Receiving the last major bit of regulatory approval in late July, for the development of harbour facilities, removed a chunk of uncertainty, and a reduction in costing estimates has provided another boost — predicted costs for the first and second stages of construction are now down 18%. Interim results released on 16 August also included an increased estimate of the likely polyhalite potash reserve, and reported further take-off agreements.

I’ve been optimistic about Sirius from the start, but it’s always been a risky investment with cost estimates necessarily uncertain and the eventual sources of funding unknown. It’ll still be years before there’s any profit coming in, but recent developments are positive and I still see Sirius Minerals as a decent speculative punt.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Alan Oscroft owns shares of Aviva. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »